Express Scripts' Friendly Data Play
Executive Summary
PBMs have historically positioned themselves as drug-industry antagonists, pushing generic substitution and aggressively driving prices lower. But now one independent PBM is arguing that far from being in the enemy camp, branded pharmaceuticals, even high cost ones, can actually contribute to reducing overall medical costs by lowering spending in other areas. And they're developing the data to prove it.